Microbix Biosystems, a manufacturer and exporter of life science solutions, announced it will collaborate with Seegene USA, a developer of multiplex molecular assays and automated solutions for U.S. labs. 

Under the parties’ collaboration, Seegene USA will distribute and recommend Microbix’s Quality Assessment Products (QAPs) to monitor the workflow accuracy of Seegene Novaplex and Allplex assays in the United States.

Microbix QAPs are available to support PCR-based (molecular) assays formatted on Copan FLOQSwabs and room-temperature stable, or in liquid vial format that are refrigerator-temperature stable. Microbix PROCEEDx brand QAPs are Research Use Only “RUO” samples, while its REDx brand QAPs are In-Vitro Diagnostic “IVD” Controls. Regular use of QAPs helps ensure the accuracy of laboratory-conducted assays.

“Our longstanding relationship with Seegene Canada laid a strong foundation for this Microbix – Seegene USA relationship,” says Philip Casselli, SVP of business development, Microbix Biosystems. “Our collaboration naturally aligns the two companies to help assure optimal results for laboratories performing high-multiplex PCR testing using Seegene Assays. This week we began our training and comprehensive support of the Seegene USA team.”

Further reading: Seegene to share Syndromic PCR Tech for Pandemic Prevention

With this agreement, Seegene USA will begin offering Microbix’s QAPs products, alongside its current portfolio of high multiplex PCR assays that test for infectious disease pathogens under its Allplex and Novaplex brands. These assays, using Seegene proprietary technology, produce high-multiplex results from a single channel in a PCR reaction.

“In this partnership, we are again increasing our IVD presence for the U.S. and further supporting our lab customers in their mission to better provide quality results for their patients and institutions,” says Craig Howell, SVP for marketing of Seegene USA, Inc. “As well, we believe our ongoing IVD assay development requires custom control and validation panel expertise that is met by Microbix’s competencies.”